The effect of aberrant maspin expression on the invasive ability of pancreatic ductal adenocarcinoma cells

Oncology Reports

Volumn 21, Issue 2, 2009, Pages 425-430

  Hong, Sung Noh ^a   Lee, Jong Kyun ^b   Choe, Won Hyoek ^a   Ha, Hye Young ^a   Park, Kyoungsook ^c   Sung, In Kyung ^a   Lee, Kyu Taek ^b   Kim, Jae J ^b   Rhee, Jong Chul ^b  

^a Konkuk University Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

In vitro invasion assay; Invasive ability; Maspin; Pancreatic ductal adenocarcinoma

Indexed keywords

ADENINE; COMPLEMENTARY DNA; GUANINE; MASPIN; SERINE PROTEINASE INHIBITOR; SERPIN B5; SERPIN-B5; TUMOR MARKER;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOLECULAR CLONING; MUTANT; NUCLEOTIDE SEQUENCE; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN VARIANT; WILD TYPE; BIOSYNTHESIS; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; NORTHERN BLOTTING; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SERPINS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL;

EID: 62849106708     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000240     Document Type: Article

References (25)

1. Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263: 526-529, 1994.
2. Maass N, Biallek M, Rosel F, Schem C, Ohike N, Zhang M, Jonat W and Nagasaki K: Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer. Biochem Biophys Res Commun 297: 125-128, 2002.
3. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJ and Sager R: Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93: 11669-11674, 1996.
4. Zhang M, Volpert O, Shi YH and Bouck N: Maspin is an angiogenesis inhibitor. Nat Med 6: 196-199, 2000.
5. Jiang N, Meng Y, Zhang S, Mensah-Osman E and Sheng S: Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene 21: 4089-4098, 2002.
6. Bailey CM, Khalkhali-Ellis Z, Seftor EA and Hendrix MJ: Biological functions of maspin. J Cell Physiol 209: 617-624, 2006.
7. Futscher BW, O'Meara MM, Kim CJ, Rennels MA, Lu D, Gruman LM, Seftor RE, Hendrix MJ and Domann FE: Aberrant methylation of the maspin promoter is an early event in human breast cancer. Neoplasia 6: 380-389, 2006.
8. Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R and Hendrix MJ: maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 58: 5681-5685, 1998.
9. Shi HY, Zhang W, Liang R, Abraham S, Kittrell FS, Medina D and Zhang M: Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res 61: 6945-6951, 2001.
10. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W and Nagasaki K: Expression of the tumor suppressor gene Maspin in human pancreatic cancers. Clin Cancer Res 7: 812-817, 2001.
11. Oh YL, Song SY and Ahn G: Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis. Appl Immunohistochem Mol Morphol 10: 62-66, 2002.
12. Ohike N, Maass N, Mundhenke C, Biallek M, Zhang M, Jonat W, Luttges J, Morohoshi T, Kloppel G and Nagasaki K: Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Lett 199: 193-200, 2003.
13. Lim YJ, Lee JK, Jang WY, Song SY, Lee KT, Paik SW and Rhee JC: Prognostic significance of maspin in pancreatic ductal adenocarcinoma. Korean J Intern Med 19: 15-18, 2004.
14. Cao D, Zhang Q, Wu LS, Salaria SN, Winter JW, Hruban RH, Goggins MS, Abbruzzese JL, Maitra A and Ho L: Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases. Mod Pathol 20: 570-578, 2007.
15. Umekita Y, Hiipakka RA and Liao S: Rat and human maspins: structures, metastatic suppressor activity and mutation in prostate cancer cells. Cancer Lett 113: 87-93, 1997.
16. Lee SH, Zhang W, Choi JJ, Cho YS, Oh SH, Kim JW, Hu L, Xu J, Liu J and Lee JH: Overexpression of the thymosin beta-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis. Oncogene 20: 6700-6706, 2001.
17. Tajima H, Ohta T, Elnemr A, Yasui T, Kitagawa H, Fushida S, Kayahara M, Miwa K, Wakayama T, Iseki S and Yokoyama S: Enhanced invasiveness of pancreatic adenocarcinoma cells stably transfected with cationic trypsinogen cDNA. Int J Cancer 94: 699-704, 2001.
18. Fitzgerald M, Oshiro M, Holtan N, Krager K, Cullen JJ, Futscher BW and Domann FE: Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control. Neoplasia 5: 427-436, 2003.
19. Sato N, Fukushima N, Matsubayashi H and Goggins M: Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 23: 1531-1538, 2004.
20. Khalkhali-Ellis Z: Maspin: the new frontier. Clin Cancer Res 12: 7279-7283, 2006.
21. Domann FE, Rice JC, Hendrix MJ and Futscher BW: Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 85: 805-810, 2000.
22. Rose SL, Fitzgerald MP, White NO, Hitchler MJ, Futscher BW, De Geest K and Domann FE: Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Gynecol Oncol 102: 319-324, 2006.
23. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA and Hendrix MJ: The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8: 2924-3932, 2002.
24. Feinberg AP and Vogelstein B: Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301: 89-92, 1983.
25. Dunn BK: Hypomethylation: one side of a larger picture. Ann NY Acad Sci 983: 28-42, 2003.